Gerrit Franciscus Landolt

60 year

Health Technology

Consumer Services

Profile

Gerrit Franciscus Landolt worked as a Director of Intellectual Property & Legal at deVGen NV from 2000 to 2004.
He then worked as a Vice President of Intellectual Property & Legal at Ablynx NV from 2004 to 2018.
Landolt received his undergraduate and graduate degrees from the University of Leiden and a graduate degree from the University of Antwerp.

Former positions of Gerrit Franciscus Landolt

Companies	Position	End
ABLYNX	General Counsel	31/12/2017
deVGen NV deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.	General Counsel	31/12/2003

See the detail of Gerrit Franciscus Landolt's experience

Training of Gerrit Franciscus Landolt

University of Leiden	Graduate Degree
University of Antwerp	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gerrit Franciscus Landolt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
deVGen NV deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.	Health Technology
Ablynx NV Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium.	Health Technology